Prevalence and genotyping of HPV in cervical cancer among Australian women

International Journal of Gynecology and Obstetrics

Volumn 67, Issue 3, 1999, Pages 163-168

  Chen, S ^a   O'Sullivan, H ^a   Tabrizi, S N ^a   Fairley, C K ^b   Quinn, M A ^a   Garland, S M ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cervical cancer; HPV; Tumor histology

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; METASTASIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0032726126     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00167-8     Document Type: Article

References (24)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1995. Int J Cancer. 54:1993;594-606.
2. Shah K.V. Human papillomaviruses and anogenital cancers. NEJM. 337:1997;1386-1388.
3. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries - Cancer in Australia 1991-1994 (with projections to 1998). Canberra: Australian Institute of Health and Welfare (Cancer Series No.7).
4. Condon J. Cancer in the Northern Territory. 1996;NT Government Printer, Darwin.
5. Munoz N., Bosch F.X. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull PAHO. 30:1996;362-377.
6. Richart R.M., Masood S., Syrjanen K.S., Vassilakos P., Kaufman R.H., Meisels A. et al. Human papillomavirus: IAC task force summary. Acta Cytol. 43:1998;50-58.
7. Schiffman M.H., Bauer H.M., Lorincz A.T., Mannos M.M., Byrne J.C., Glass A.G. et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. Clin Microbiol. 29:1991;573-577.
8. Schiffman M.H. Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. vol. 19 169-179. 1992;IARC Scientific Publications, Lyon, France.
9. Schiffman M.H., Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. 54:1994;1944s-1947s.
10. Franco E.L. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence. Cancer Epidemiol Biomarkers Prev. 1:1992;499-504.
11. Labropoulou V., Diakomanolis E., Dailianas S., Kalpaktsoglou K., Balamotis A., Mavromara P. Type-specific prevalence of genital human papillomaviruses in benign, premalignant, and malignant biopsies in patients from Greece. Sex Transm Dis. 24(8):1997;469-474.
12. Chaouki N., Bosch F.X., Munoz N., Meijer C.J.L.M., Gueddari B.E., Ghazi A.E. et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer. 75:1998;546-554.
13. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. NY.
14. Ting Y., Mannos M.M. Detection and typing of genital human papillomaviruses. Innis M., Gelfand D., Sninsky J., White T. PCR protocols: a guide to methods and applications. 1990;356-367 Academic Press Inc, San Diego, California.
15. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro C.J., Chimera J. et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. J Am Med Assoc. 265(4):1991;472-477.
16. Zehbe I., Wilander E. Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology. J Pathol. 181(3):1997;270-275.
17. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J. et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 87:1995;796-802.
18. Cuzick J., Terry G., Ho L., Hollingworth T., Anderson M. Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancer. Lancet. 339:1992;956-959.
19. Kurman R.J., Schiffman R.M., Lancaster W.D., Reid R.R., Jenson A.B., Temple G.F. et al. Analysis of individual human papillomavirus type in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol. 159:1988;293-296.
20. Smotkin D., Berek J.S., Fu Y.S., Hacker N.F., Major F.J., Wettstein F.O. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol. 68:1986;241-244.
21. Stoler M.H., Mills S.E., Gersell D.J., Walker A.N. Small cell neuroendocrine carcinoma of the cervix: a human papillomavirus type 18 associated cancer. Am J Surg Pathol. 15:1991;28-32.
22. Higgins G.D., Davy M., Roder D., Uzelin D.M., Phillips G.E., Burrell C.J. Increased age and mortality associated with cervical carcinoma negative for human papillomavirus DNA. Lancet. 338:1991;910-913.
23. Mitrani-Rosenbaum S., Tsvieli R., Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol. 70:1989;2227-2232.
24. Girardi F., Fuchs P., Haas J. Prognostic importance of human papillomavirus type 16 DNA in cervical cancer. Cancer. 69:1992;2502-2504.